0232 233 387 info@consultmed.ro

INNOVATIVE TREATMENTS

determining the risk of diabetes with Ezscan

Determining the risk of diabetes and complications.

Screening for prediabetes / diabetes is currently based on glucose level measurement – a test that is already known to have a low sensitivity and generates a large number of false negative results.

EZSCAN is a technology developed by the French company Impeto Medical for early diagnosis and determination of the risk of diabetes and its associated complications.

EZSCAN allows the early detection of peripheral nerve complications to optimize diabetes screening, prevention and management policies, thus being a safe, non-invasive and painless method.

You can find out more information by calling us directly on 0232 233 387 or by making an online appointment: